Literature DB >> 5285374

The kinetics of heparin.

J W Estes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5285374     DOI： 10.1111/j.1749-6632.1971.tb46899.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Exogenous 35S-labeled heparin: organ distribution and metabolism.

Authors:  T Stau; J Metz; R Taugner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

2.  Pharmacokinetic modeling of heparin and its clinical implications.

Authors:  T J McAvoy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

Review 3.  Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.

Authors:  Joshua A Stone; Joshua Z Willey; Salah Keyrouz; James Butera; Ryan A McTaggart; Shawna Cutting; Brian Silver; Bradford Thompson; Karen L Furie; Shadi Yaghi
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

Review 4.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 5.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

6.  Inhibitory effect of heparin on gentamicin concentrations in blood.

Authors:  C Regamey; D Schaberg; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

Review 7.  Protamine--antagonist to heparin.

Authors:  L B Jaques
Journal:  Can Med Assoc J       Date:  1973-05-19       Impact factor: 8.262

Review 8.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

Review 9.  Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease.

Authors:  Eman Abdelghani; Clifford L Cua; Jean Giver; Vilmarie Rodriguez
Journal:  Cardiol Ther       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.